Treatment with mesenchymal stem cells suppresses hepatic macrophage activation
الخلايا الجذعية الوسيطة (MSC) therapy shows promise in suppressing hepatic macrophage activation, a key driver of liver inflammation. Our study analyzes the mechanisms underlying this effect, revealing potential new therapeutic avenues for liver diseases. Learn more about our findings.